Stay updated with breaking news from Bighat Mark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbbVie Inc. (NYSE: ABBV) and BigHat Biosciences announced a research collaboration to discover and develop next-generation therapeutic antibodies in oncology and neuroscience. Working closely with AbbVie, BigHat will utilize its Milliner™ platform, a ...
AbbVie Inc. (NYSE: ABBV) and BigHat Biosciences announced a research collaboration to discover and develop next-generation therapeutic antibodies in oncology and neuroscience. Working closely with AbbVie, BigHat will utilize its Milliner™ platform, a ...